Silver Book Fact

HVD patients knew little prior to their diagnosis

More than 2/3 of valve disease patients knew a limited amount or nothing about heart valve disease (HVD) before their diagnosis.

Report of Findings from Opinion Research among Heart Valve Disease Patients. https://www.agingresearch.org/press-release/alliance-launches-aortic-stenosis-awareness-campaign/. Published 2016. Accessed October 16, 2017

Reference

Title
Report of Findings from Opinion Research among Heart Valve Disease Patients
Publication Date
Published 2016
Authors
Belden Russanello Strategists
URL
Read Full Resource

Related Facts

  • SAS patient hospitalization costs
    Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • Many cases of HVD are diagnosed during a routine physical check-up
    Six in 10 patients did not have or recognize symptoms of heart valve disease (HVD) and were only diagnosed after going to their doctor for a regular check-up or a…  
  • Increased hospital admissions and prolonged length of stay for patients who do not undergo treatment
    Medicare severe symptomatic aortic stenosis (sSAS) patients who do not undergo treatment have an average of 1.9 hospital admissions per year and prolonged lengths of stay — 11.5 hospital days…  
  • Improvements in QoL from TAVR in SAS patients
    Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)…